Nanoparticles for use in enhancing brain performance or treating stress - Patents.com

Nanoparticles and nanoparticle aggregates enhance brain performance and treat stress without requiring electric fields or other external activation sources, addressing the side effects of existing treatments and leveraging their size-dependent properties and biocompatible coatings.

JP7758381B2Active Publication Date: 2025-10-22NANOBIOTIX SA
View PDF 1 Cites 0 Cited by

Patent Information

Application Number
JP2024033926
Authority / Receiving Office
JP · JP
Patent Type
Patents
Current Assignee / Owner
Priority Date
2017-12-19
Filing Date
2024-03-06
Publication Date
2025-10-22
Estimated Expiration
2038-12-18

Smart Images

  • Figure 0007758381000004
    Figure 0007758381000004
  • Figure 0007758381000005
    Figure 0007758381000005
  • Figure 0007758381000006
    Figure 0007758381000006
Patent Text Reader

Abstract

To provide nanoparticles and / or nanoparticles' aggregates for use in enhancing, increasing or improving brain performances / capacities or for preventing or treating pathological stress or at least one symptom thereof.SOLUTION: The present invention provides nanoparticles or nanoparticles' aggregate for use in enhancing learning, memory, and attention in a subject or preventing or treating pathological stress due to changes in synaptic plasticity or connectivity, without exposure of the nanoparticles or nanoparticles' aggregate to an electric field or to any other external activation source, wherein the material for the nanoparticles or nanoparticles' aggregate is selected from an insulator material with a band gap Eg of 3.0 eV or more and a dielectric constant εijk of 200 or more, which is BaTiO3, and an insulator material, with a band gap Eg of 3.0 eV or more and a dielectric constant εijk of 100 or less, which is selected from ZrO2 and HfO2.SELECTED DRAWING: None
Need to check novelty before this filing date? Find Prior Art

Citation Information

Patent Citations

  • Materials and Methods for the Delivery of a Nanocarrier to the Brain

    US20170290916A1